| Financial Year |
March 31 2023 |
| Monetary Funds |
1,590,526,531.53 |
| Held-for-trading Financial Assets |
607,525,771.45 |
| Notes Receivable |
334,252,827.24 |
| Accounts Receivable |
2,399,776,069.55 |
| Advances to Suppliers |
23,620,073.32 |
| Other Receivables |
39,762,833.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,130,980,700.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,381,458.58 |
| Total Current Assets |
6,313,352,148.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
6,289,527,348.20 |
| Under-construction Projects |
128,090,350.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
189,159,053.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
44,442,246.86 |
| Deferred Income Tax Assets |
33,361,606.45 |
| Other Non-Current Assets |
161,562,825.93 |
| Sub-Total of Non-Current Assets |
8,260,083,215.53 |
| Total Assets |
14,573,435,364.04 |
| Short-Term Loans |
2,923,733,094.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,740,872,397.00 |
| Accounts Payable |
1,538,187,889.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
91,514,605.92 |
| Taxes Payable |
86,070,113.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
93,491,026.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
162,998,850.29 |
| Other Current Liabilities |
37,118,502.67 |
| Sub-Total of Current Liabilities |
6,682,519,223.49 |
| Long-term Loans |
725,145,666.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
37,305,952.20 |
| Other Non-Current Liabilities |
1,226,513.11 |
| Sub-Total of Non-Current Liabilities |
847,133,620.06 |
| Total Liabilities |
7,529,652,843.55 |
| Paid-In Capital(Or Share Stock) |
862,688,641.00 |
| Capital Surplus |
3,258,101,397.34 |
| Surplus Reserve |
328,262,374.23 |
| LESS:Treasury Stock |
150,106,550.41 |
| Undistributed Profits |
2,605,207,118.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,043,782,520.49 |
| Owner's Equity（Stockholder's Equity） |
7,043,782,520.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,573,435,364.04 |
